Afuco™ Anti-FLT1 ADCC Recombinant Antibody (Icrucumab), ADCC Enhanced (CAT#: AFC-TAB-177)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to VEGFR-1. Icrucumab is a human monoclonal antibody designed for the treatment of solid tumors.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • Recombinant human soluble extracellular Flt-1 Ig-like loop 1 to 5 (sFlt-1(D5)).
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Icrucumab
  • Applications
  • IF, IP, Neut, FuncS, ELISA, FC
  • Conjugate
  • Unconjugated
  • Generic Name
  • Icrucumab
  • Related Disease
  • Colon cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Icrucumab; 1024603-92-6; IMC-18F1; IMC18F1; FLT1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor); FLT; vascular endothelial growth factor receptor 1; VEGFR1; FLT-1; VEGFR-1; fms-like tyrosine kinase 1;

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Icrucumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Icrucumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Icrucumab"

Anti-Human VEGFR-1 Recombinant Antibody (Icrucumab)
Recombinant monoclonal antibody to VEGFR-1. Icrucumab is a human monoclonal antibody designed for the treatment of solid tumors.

See other products for "FLT1"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Mouse Antibody Products Chimeric Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products ScFv Antibody Products Fab Antibody Products IgG Antibody Products MHC Tetramer Products for Cancer
CAT Product Name Application Type
TAB-177 Anti-Human VEGFR-1 Recombinant Antibody (Icrucumab) IF, IP, Neut, FuncS, ELISA, FC, WB IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-177. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare